FDA denial could delay launch of Minerva’s schizophrenia treatment roluperidone by at least two years: GlobalData Read more
Lilly issues Complete Response Letter for Sintilimab in combination with Pemetrexed and Platinum chemotherapy for NSCLC treatment Read more
Successive drug launches will drive growth of NASH market in seven major markets: GlobalData Read more
US FDA denies approval to Mallinckrodt for Terlipressin to treat Hepatorenal Syndrome Type 1 Read more